Zachary R. Zener

Zachary R. Zener

Auto-generated profile, based on publicly available information

Zachary R. Zener

Department of Medicine, Section of Hematology and Medical Oncology, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, MA, USA

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 July 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
GBGwendolyn M. Beacham
Gwendolyn M. Beacham
ZIZewde Ingram
Zewde Ingram
REReema A. Elrefaie
Reema A. Elrefaie
KEKhaliun Enkhbayar
Khaliun Enkhbayar
ZZZachary R. Zener
Zachary R. Zener
EHElliott J. Hagedorn
Elliott J. Hagedorn
Hematopoietic stem and progenitor cell (HSPC) niches support lifelong production of blood and immune cells. Recently, we identified a gene signature unique to HSPC niche endothelial cells that is highly conserved across species and developmental time and includes the scavenger receptors stab1/2 and mrc1a . Whether these receptors support HSPC development remains unclear. To investigate this, we used chemical inhibition and CRISPR mutagenesis in zebrafish and found that loss of stab2 , and to a lesser degree stab1 , reduced the number of embryonic runx1 (+) HSPCs. Subsequent analyses of an additional HSPC marker ( cd41 ) revealed an imbalance in the HSPC pool in stab2 mutants, with reductions in runx1 (+) cd41 (+) and runx1 (+) cd41 (-) sub-populations containing stem cells and erythroid progenitors, respectively, the latter of which was most decreased. Our findings suggest stabilin scavenger receptors support HSPC development in the fetal niche, which could inform clinical strategies for culturing and expanding HSPCs.